# ARS Pharmaceuticals, Inc.: Form 8-K, filed Sep 23, 2024

- Company: [ARS Pharmaceuticals, Inc.](/companies/spry.md) (CIK 1671858)
- Form: 8-K
- Filed: 2024-09-23
- Accepted by EDGAR: Sep 23, 2024, 16:15 ET
- Period: 2024-09-17
- Accession: 0001193125-24-223676
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1671858/000119312524223676/d834306d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1671858/000119312524223676/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1671858/000119312524223676/d834306d8k.htm

Filed Sep 23, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-223676. Last ingested by Listed: Nov 10, 2026, 04:18 ET. No prices; not investment advice.